Pegylated reconstituted high-density lipoprotein nanoparticles
AssigneeMepsgen Co., Ltd.
InventorsWooseung LEE, Jin KIM, Yong Tae KIM
Life of this patent
Estimating the term…
Loading patent…
AssigneeMepsgen Co., Ltd.
InventorsWooseung LEE, Jin KIM, Yong Tae KIM
Estimating the term…
PEGylated reconstituted high-density lipoprotein nanoparticles having the effect of preventing or treating neurodegenerative diseases are provided. Specifically, the present invention relates to nanoparticles and a method for producing the same, a phospholipid layer of the produced nanoparticles being protected by PEG due to PEG-lipid or a derivative thereof being included in the process of preparing a fluid comprising a hydrophobic material and a fluid comprising a hydrophilic material. The PEGylated nanoparticles have the ability to avoid the rejection mechanism of the immune response in the body while maintaining the existing transport ability across the blood-brain barrier, thereby having excellent stability and exhibiting long-term pharmacological effect due to high circulation ability in the body, and thus can be effectively utilized as a drug or a drug carrier.
A PEGylated reconstituted high-density lipoprotein (rHDL) nanoparticle comprising a PEGylated lipid, a phospholipid, and apolipoprotein E, wherein the synthetic mixing molar ratio of the apolipoprotein E and the PEGylated lipid is 1:0.5 to 1:50.
A method for producing PEGylated reconstituted high-density lipoprotein (rHDL) nanoparticles comprising a PEGylated lipid, a phospholipid, and apolipoprotein E, wherein the method comprises:
Dependencies are inferred from the claim text.